EUVIMEDEUVIMED entdecken
Crossref

Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds

Matthew Garoufalis, Darshan Nagesh, Patrick J Sanchez, Robin Lenz, Sarah J Park, Jake G Ruff, Anna Tien, Justin Goldsmith, Andrea Seat

Journal of the American Podiatric Medical Association · 01.03.2018 · 108 (2) · 84-89

DOI: 10.7547/17-039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Podiatric Medical Association, erschienen am 01.03.2018. Verfasst von Matthew Garoufalis und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Wound Healing. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biochemical properties of the amniotic membrane help modulate inflammation and enhance soft-tissue healing. In controlled trials, the efficacy of dehydrated human amnion/chorion membrane (dHACM) allografts has been established. Our purpose is to describe our experience with using dHACM to treat nonhealing wounds of various etiologies.

Methods

We conducted a retrospective review of deidentified data from 117 consecutive patients treated in an outpatient clinic with dHACM allografts with wounds of various etiologies over 2 years. The decision to use advanced wound-care treatments is based on rate of healing observed after initiation of standard wound care and patient risk factors. Eligibility for treatments such as amniotic membrane allografts includes wounds without 50% reduction after 4 weeks, or earlier in patients deemed to be at high risk for nonhealing or with a history of chronic wounds. In micronized or sheet formulation, dHACM is applied to the wound weekly after sharp/mechanical debridement as necessary, and wound-care practices appropriate for wound type and location are continued.

Results

Thirty-four percent of allograft recipients had diabetic foot ulcers, 25% had venous leg ulcers, 20% had surgical wounds, 14% had pressure ulcers, 6% had ischemic wounds, and 2% had traumatic wounds. Complete healing occurred in 91.1% of treated patients, with a mean ± SD number of weekly applications per healed wound of 5.1 ± 4.2.

Conclusions

In addition to wounds of diabetic origin, dHACM can significantly expedite healing in refractory wounds of varying etiologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingAdultAgedAged, 80 and overAllograftsAmnionChorionFemaleHumansMaleMiddle AgedRetrospective StudiesTreatment OutcomeWounds and Injuries

Zitieren

APA

Garoufalis, M., Nagesh, D., Sanchez, P. J., Lenz, R., Park, S. J., Ruff, J. G., Tien, A., Goldsmith, J., & Seat, A. (2018). Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds. Journal of the American Podiatric Medical Association, 108(2), 84-89. https://doi.org/10.7547/17-039

Vancouver

Garoufalis M, Nagesh D, Sanchez PJ, Lenz R, Park SJ, Ruff JG, et al. Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds. Journal of the American Podiatric Medical Association. 2018;108(2):84-89. doi:10.7547/17-039

BibTeX
@article{Garoufalis2018,
  author = {Garoufalis, Matthew and Nagesh, Darshan and Sanchez, Patrick J and Lenz, Robin and Park, Sarah J and Ruff, Jake G and Tien, Anna and Goldsmith, Justin and Seat, Andrea},
  title = {Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds},
  journal = {Journal of the American Podiatric Medical Association},
  year = {2018},
  volume = {108},
  number = {2},
  pages = {84--89},
  doi = {10.7547/17-039}
}
Kostenlos starten →